Deltex Medical Share Discussion Threads

[gbenson1] 31/10/2018 18:29

Wondered why the Sp was reluctant to move up despite a few buys @ 1.30. Not sure who sold the 1m+ whether an investor or a company move?

[yump] 07/10/2018 12:17

Someone posted that someone else was ramping, which seemed funny, given that the first someone has consistently posted negative stuff, which is common on all threads that poster bothers to post on. In detail as well. I can only think that there is a group of rather sad bottom pickers around. Perhaps it is a deliberate ploy to extract the very last pi's from the stock. When the thread goes completely quiet and all the posters are disillusioned, then they buy a few.

Or maybe they're just sad and have no strategy.

[gspanner] 05/10/2018 18:37

Too cryptic for me Yump.

[yump] 05/10/2018 17:00

Ramping ??!!

Analysts exam question:

"So for your next question, give an example of ramping on the stock market"

"DEMG"

"Sorry, I'm afraid you've failed immediately. There is a choice of hundreds of companies and you've picked one where the emphasis has been on detailed pointless criticism."

[gspanner] 05/10/2018 16:08

Yes indeed - they only need one person in marketing now to go and pitch DEMG to a larger medical device company!

[msufi77] 05/10/2018 14:03

another million buy today

[msufi77] 27/9/2018 10:55

re-rate in progress big buy n hold going to be massive mms short on stock nt trade only

[janatha] 25/9/2018 17:06

buywell3

I refer you to 9600.

[buywell3] 25/9/2018 14:58

You did the chairman bit at DDD too , it went into administration soon afterwards

janatha - 13 Jun 2015 - 10:15:05 - 30674 of 31118 DDD to hit 10 quid - DDD
kreature

Excellent. Great to see the chairman buying a sizeable chunk of shares. Real vote of confidence in Chris Yewdall and DDD.

[janatha] 25/9/2018 12:50

Wonder if the chairman is tucking in again - 1.5m bought at 1.24p.

[mrc2u] 25/9/2018 11:07

DJFair comments. However the debtors always go down in H1 and seem to be covered by invoice discounting so most cash collected when sale is made. Point about the payables is that they must have stretched all and sundry when things were tight so the half mil catch up is a one off, as are the exceptionalsWould be helpful if they explained this but looks like they were at or close to cash break even even before the latest round on cost savings which should take them into positive cash flows. Once market gets this, price should trebleI hopeMrC

[janatha] 25/9/2018 10:47

parsons4

Agreed. Bought yesterday and some more today even though I said I would wait till they dropped to c 1p.

[parsons4] 25/9/2018 10:37

Just listened to the interview with Andy Mears on Directors talk. Very positive, I think the new strategy is correct and Deltex are a good recovery stock. I increased my holdings yesterday on the back of the statement and figures. GLA to all believers !!

[janatha] 25/9/2018 09:26

buywell3

Small tech stocks are almost by definition speculative. Some will fly others will founder.

Sold half my holding in DDD when the share price was near it's peak, the other half went down to 0p. Overall I made a small profit.

Will continue to back small growth and turnaround companies as I find it more lucrative and personally rewarding than sticking money in the likes of HSBC.

[buywell3] 25/9/2018 08:55

janatha

Thanks for your kind words and I have done some more research

Re DDD , I urge anyone interested to look at this gentlemen's positive DDD posts over many, many years



Last post on the thread

pr1003 Apr '18 - 11:23 - 31117 of 31117
0 0 0

12 March 2018

DDD Administrator appointed: FRP Advisory LLP

DDD Administration microsite: hxxp://creditors.frpadvisory.com

CASE CODE: D1258LON



Last DDD post by janatha


janatha - 24 May 2016 - 08:18:17 - 31092 of 31118 DDD to hit 10 quid - DDD
cgod

Agreed.Just think there is a hiatus in cash-flow and when revenue picks up from current crop of products value will follow. share price does not reflect this or potential of Litigation win against LG.

[janatha] 25/9/2018 08:54

gspanner

Fair point.

Though, personally I hope the management and shareholders say no to any offer and give the new chief executive a chance to turn things around. If he succeeds in stabilising DM and achieves break even on a monthly basis then the share price will be a whole lot higher than it is now, even if you add a 50% bid premium to the current share price Though as Warren Buffett would say the trouble with turn arounds is they don't.

[maxk] 25/9/2018 08:42

What price do you think would be acceptable to the larger shareholders?

Most are in at much higher prices, and I suspect would be loath to sell at this level.

[gspanner] 25/9/2018 08:36

I do think everyone here is rather missing the point. The company is now a great takeover target for a large medical equipment company with a developed marketing department. They have even ‘streamlined’ the current workforce to make it easier. Could pick up the proven morbidity reducing (ie money saving)tech (having done the expensive trials) for a song. Repackage and market in a way (probably by government lobbying forcing hospitals to use/NICE assessment).

Voilà

[janatha] 25/9/2018 08:35

buywell3

"So I do not agree with this ... IMO ramp"

janatha - 03 Sep 2018 - 11:25:18 - 9507 of 9594 Deltex Medical - a British success story! - DEMG
"Have been in and back out a long time ago but am back in now. So much bad news is already in the price. Nigel Keen is hoovering up shares which is reassuring and implies things are stabilising."

- If this is a ramp it is one with a minuscule gradient. Indeed when the share price was recently charging up I warned short term speculative traders that nothing significant would be announced short term and that they were running ahead of themselves and were in danger of getting their fingers burnt. So not guilty as charged.


Another DEMG ramp when the DEMG share price was much higher at 12p

janatha - 06 Nov 2008 - 12:03:35 - 4863 of 10006 Deltex Medical-Optimal Growth Stock - DEMG

"At these levels and with it's enormous potential/hugely encouraging newsflows it is a sitting duck.IMHO/DYOR it is only a matter of time.Why would a potential acquirer hang around for the share price to play catch up. Hopefully the main shareholders will stand firm and not sell out on the cheap."

Again, in my defence, the Sp subsequently went up to 30p in 2012. You would have nearly trebled your money over 3 1/2 yrs if you had taken my advice in 2008 and sold in 2012.

But Wow how time flies. Thank you for your diligent research in this matter.

[buywell3] 25/9/2018 07:48

Once again I have to put the other point of view here re ramping of shares

So far in the last 2 months 80M DEMG shares have been sold ...

Hambro have sold around 37M or circa 6% of their 9% plus holding so another 43M to account for


On the buy side we have seen ONLY Mr Keen

NO OTHER INSTITUTIONS

So I do not agree with this ... IMO ramp

janatha - 03 Sep 2018 - 11:25:18 - 9507 of 9594 Deltex Medical - a British success story! - DEMG
Have been in and back out a long time ago but am back in now. So much bad news is already in the price. Nigel Keen is hoovering up shares which is reassuring and implies things are stabilising.









Another DEMG ramp when the DEMG share price was much higher at 12p



janatha - 06 Nov 2008 - 12:03:35 - 4863 of 10006 Deltex Medical-Optimal Growth Stock - DEMG

At these levels and with it's enormous potential/hugely encouraging newsflows it is a sitting duck.IMHO/DYOR it is only a matter of time.Why would a potential acquirer hang around for the share price to play catch up. Hopefully the main shareholders will stand firm and not sell out on the cheap.







160M volume of shares traded in the last 2 months now with the 15M yesterday

ie 80M sells 80M buys


Hambro have most likely sold out the rest of their 18.6M holding


But at least one other Institution must have bailed out or cut their stake significantly

From yesterdays results this won't help

''Current trading and prospects


The Board notes that, as a result of the previously reported poor trading in H1 2018 and the implementation of the new strategy, revenues for the year ending 31 December 2018 will be behind market expectations and lower than those reported in 2017.''



IMO losses for 2018 look like coming in once more at around the £2M mark

Present cash of around £1M IMO will last till this xmas BUT more will be needed in early 2019

So further dilution looks likely and with revenues continuing to fall and market share shrinking , a discount to the prevailing share price at the time of a fund raise looks set to be IMO 30% to stand a chance of raising more cash , another £2M will be needed.


Last time cash was raised not many wanted to play ball

Next time might be the final whistle .

Several Institutions have been invested in DEMG for many years and watched their holding shrink in value by circa 90%

Will those selling now start the others to also exit ? or have they now written their holdings off ?


IMO next raise will be at 0.5p and over 1 Billion DEMG shares will be on the market

Also the loan notes 4p , with the redemption price set at 6p now reduced to 4p and with an extended time frame for share conversion will IMO get reduced again to 2p hence another dilution to come with yet another time extension .

DEMG are paying 8% interest on these

[janatha] 25/9/2018 07:29

yump

"a business......in any growing volume." Fair comment. Though I would say they overestimated the length of time of general acceptance (who didn't?)and the sales momentum/growth and have cut their cloth accordingly.

[buywell3] 25/9/2018 07:27

160M volume of shares traded in the last 2 months now with the 15M yesterday

ie 80M sells 80M buys


Hambro have most likely sold out the rest of their 18.6M holding


But at least one other Institution must have bailed out or cut their stake significantly

From yesterdays results this won't help

''Current trading and prospects


The Board notes that, as a result of the previously reported poor trading in H1 2018 and the implementation of the new strategy, revenues for the year ending 31 December 2018 will be behind market expectations and lower than those reported in 2017.''



IMO losses for 2018 look like coming in once more at around the £2M mark

Present cash of around £1M IMO will last till this xmas BUT more will be needed in early 2019

So further dilution looks likely and with revenues continuing to fall and market share shrinking , a discount to the prevailing share price at the time of a fund raise looks set to be IMO 30% to stand a chance of raising more cash , another £2M will be needed.


Last time cash was raised not many wanted to play ball

Next time might be the final whistle .

Several Institutions have been invested in DEMG for many years and watched their holding shrink in value by circa 90%

Will those selling now start the others to also exit ? or have they now written their holdings off ?


IMO next raise will be at 0.5p and over 1 Billion DEMG shares will be on the market

Also the loan notes 4p , with the redemption price set at 6p now reduced to 4p and with an extended time frame for share conversion will IMO get reduced again to 2p hence another dilution to come with yet another time extension .

DEMG are paying 8% interest on these

[yump] 24/9/2018 23:40

You don't really seem to get it. A business of this size that is cost-cutting has a failed business strategy. Clinicians clearly don't want a 'best in breed' in any growing volume.

The positive (perhaps) is that DEMG having that, gives them a chance to open doors to selling the new product set of 'we've got a product for whatever level of monitoring you want to do'.

Unfortunately its taken them years and years to get around to it.

[janatha] 24/9/2018 19:07

yump

"So many people........detailed negative comments." Possibly denotes a final capitulation.

"Must be so rich....." Probably not so rich after owning shares in DM. Also, am I to understand that you are not so rich and that to be so is somehow disagreeable and that, having reached those dizzy heights, rather than tearing around in a McLaren and dating models these so rich folk would much rather debate the finer points of a £5m cap. company?

If you "can sell a bit more of something or other" that constitutes incremental growth. Secondly I suggested that the "new reality is incremental growth AND absolute focus on break even, maybe even at the expense of some future sales gains. When the company breaks into profit then more of the focus can be put back again on sales growth." Absolute focus on break even, even at the expense of some future sales gains, self - evidently, entails, an absolute focus on cost - cutting, as DM is rightly now obsessed with so implementing.

Thirdly - " having survived.....what to do next" Thanks for reiterating my point - "When the company breaks into profit then more of the focus can be put back again on sales growth."